Vericel's Customers Performance

Name: Vericel Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

VCEL

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


VCEL's Source of Revenues		During the corresponding time, Vericel Corporation recorded a revenue increase by 30.09 % year on year, sequentially revenue fell by -26.36 %. While revenue at the Vericel Corporation's corporate clients • List of VCEL Customers

for the same period Vericel Corporation recorded revenue increase by 30.09 % year on year, sequentially revenue fell by -26.36 %.

• List of VCEL Customers

Vericel's Business Units


Change in estimates related to prior periods	0.02 %	of total Revenue
M A C I Implants and kits	82.42 %	of total Revenue
Through Intermediary MACI implants kits and instruments Contract rate	60.66 %	of total Revenue
Through Intermediary MACI implants kits and instruments Time-and-materials contract	7 %	of total Revenue
Time-and-materials contract MACI implants kits and instruments Time-and-materials contract	3.03 %	of total Revenue
Provider or Facility MACI implants kits and instruments Contract rate	10.83 %	of total Revenue
Provider or Facility NexoBrid	1.67 %	of total Revenue
Directly to consumer Biopsy kits	0.89 %	of total Revenue
Directly to consumer Epicel	15.91 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Vericel's Comment on Sales, Marketing and Customers

The company provides products and services to specialty pharmacies, hospitals, military facilities, burn centers, and specialty distributors. Specialty pharmacies receive a fee for dispensing MACI to patients. MACI is sold directly to hospitals and to DMS Pharmaceutical Group, Inc. for use at U.S. military facilities. The burn care commercial team targets approximately 140 U.S. burn centers, with sales representatives engaging these institutions. Epicel is sold directly to hospitals and burn centers through contracts or purchase orders. NexoBrid is sold to specialty distributors, who then resell it to hospitals and burn centers. The company also employs third-party contractors to manage patient support programs, including case management and billing information.

Vericel’s Comment on Sales, Marketing and Customers

VCEL's Stock Performance relative to it's Customers

VCEL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Vericel Corporation	1,974.56	292.09	21.46	398
SUBTOTAL	0.00	0.00	0.00	-

Sources: Vericel Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Vericel Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Vericel Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.